Modeling Gasotransmitter Availability to Brain Capillary Endothelial Cells with Ultrasound-sensitive Microbubbles
Rubens Jourdain1, Venkat Keshav Chivukula1, Chris A Bashur2
1Department of Biomedical, Chemical Engineering and Science, Florida Institute of Technology, 150 West University Blvd., Melbourne, FL, USA.
This study shows that delivering carbon monoxide (CO) via ultrasound-activated microbubbles (MBs) is a feasible strategy to repair the blood-brain barrier (BBB). Controlled CO delivery is key for this novel therapeutic approach.
Area of Science:
- Biomedical Engineering
- Computational Biology
- Neuroscience
Background:
- Vascular cognitive impairment and dementia stem from a compromised blood-brain barrier (BBB).
- Current treatments manage neuronal damage but not the root cause of BBB disruption.
- Existing therapies often involve temporarily disrupting the BBB, which can have adverse effects.
Purpose of the Study:
- To computationally assess the feasibility of using carbon monoxide (CO) delivered from ultrasound-sensitive microbubbles (MBs) to repair and enhance BBB integrity.
- To investigate the controlled release and transport of CO to brain capillary endothelial cells (BCECs).
Main Methods:
- Simulated ultrasound activation in the internal carotid artery to trigger MB rupture and CO release.
- Modeled CO transport dynamics, including hemodynamics, mass transport, and binding kinetics, to predict CO dose at the BBB.
- Utilized axisymmetric and patient-specific models to analyze CO availability to BCECs under various conditions.
Main Results:
- CO released from MBs remains available to interact with BCECs for several cardiac cycles.
- Predicted concentrations of CO and CO-hemoglobin (COHb) are within non-toxic levels, with free hemoglobin available.
- Biologically relevant CO concentrations can be achieved and sustained in BCECs through controlled ultrasound activation, even in tortuous vasculature.
Conclusions:
- The computational findings support the feasibility of the CO/MB strategy for BBB repair.
- Controlled ultrasound-mediated delivery of CO is crucial for the therapeutic viability of this approach.
More Related Videos
06:02Multi-timescale Microscopy Methods for the Characterization of Fluorescently-labeled Microbubbles for Ultrasound-Triggered Drug Release
Published on: June 12, 2021
08:02A High-Throughput Image-Guided Stereotactic Neuronavigation and Focused Ultrasound System for Blood-Brain Barrier Opening in Rodents
Published on: July 16, 2020
